News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,310 Results
Type
Article (44813)
Company Profile (299)
Press Release (707185)
Multimedia
Podcasts (114)
Webinars (21)
Section
Business (213223)
Career Advice (2195)
Deals (36933)
Drug Delivery (125)
Drug Development (83614)
Employer Resources (177)
FDA (17262)
Job Trends (15600)
News (360729)
Policy (34658)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2668)
Accelerated approval (32)
Adcomms (27)
Allergies (146)
Alliances (52326)
ALS (174)
Alzheimer's disease (1695)
Antibody-drug conjugate (ADC) (315)
Approvals (17510)
Artificial intelligence (528)
Autoimmune disease (147)
Automation (37)
Bankruptcy (372)
Best Places to Work (11988)
BIOSECURE Act (20)
Biosimilars (196)
Biotechnology (185)
Bladder cancer (159)
Brain cancer (56)
Breast cancer (639)
Cancer (4847)
Cardiovascular disease (405)
Career advice (1855)
Career pathing (35)
CAR-T (295)
CDC (49)
Celiac Disease (2)
Cell therapy (778)
Cervical cancer (36)
Clinical research (71221)
Collaboration (1745)
Company closure (4)
Compensation (1159)
Complete response letters (56)
COVID-19 (2821)
CRISPR (95)
C-suite (839)
Cystic fibrosis (146)
Data (6218)
Decentralized trials (2)
Denatured (37)
Depression (138)
Diabetes (516)
Diagnostics (6904)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (250)
Drug pricing (203)
Drug shortages (32)
Duchenne muscular dystrophy (237)
Earnings (92891)
Editorial (57)
Employer branding (21)
Employer resources (155)
Events (122040)
Executive appointments (991)
FDA (20421)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1490)
Gene editing (203)
Generative AI (43)
Gene therapy (633)
GLP-1 (1037)
Government (4897)
Grass and pollen (8)
Guidances (386)
Healthcare (19460)
HIV (56)
Huntington's disease (46)
IgA nephropathy (81)
Immunology and inflammation (256)
Immuno-oncology (56)
Indications (105)
Infectious disease (3086)
Inflammatory bowel disease (192)
Inflation Reduction Act (14)
Influenza (114)
Intellectual property (248)
Interviews (341)
IPO (17108)
IRA (52)
Job creations (3970)
Job search strategy (1558)
JPM (62)
Kidney cancer (15)
Labor market (83)
Layoffs (581)
Leadership (30)
Legal (8422)
Liver cancer (93)
Longevity (14)
Lung cancer (650)
Lymphoma (376)
Machine learning (42)
Management (62)
Manufacturing (830)
MASH (164)
Medical device (14523)
Medtech (14577)
Mergers & acquisitions (20900)
Metabolic disorders (1318)
Multiple sclerosis (161)
NASH (16)
Neurodegenerative disease (324)
Neuropsychiatric disorders (88)
Neuroscience (2944)
Neurotech (1)
NextGen: Class of 2026 (6790)
Non-profit (4587)
Now hiring (65)
Obesity (629)
Opinion (289)
Ovarian cancer (164)
Pain (205)
Pancreatic cancer (226)
Parkinson's disease (288)
Partnered (34)
Patents (499)
Patient recruitment (479)
Peanut (58)
People (61006)
Pharmaceutical (76)
Pharmacy benefit managers (30)
Phase 1 (22247)
Phase 2 (31295)
Phase 3 (23366)
Pipeline (5169)
Policy (298)
Postmarket research (2634)
Preclinical (9425)
Press Release (71)
Prostate cancer (241)
Psychedelics (49)
Radiopharmaceuticals (288)
Rare diseases (851)
Real estate (6366)
Recruiting (70)
Regulatory (25850)
Reports (51)
Research institute (2465)
Resumes & cover letters (369)
Rett syndrome (28)
RNA editing (17)
RSV (79)
Schizophrenia (150)
Series A (250)
Series B (191)
Service/supplier (14)
Sickle cell disease (98)
Special edition (23)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3837)
State (2)
Stomach cancer (17)
Supply chain (109)
Tariffs (94)
The Weekly (75)
Vaccines (1049)
Venture capital (90)
Weight loss (416)
Women's health (89)
Worklife (19)
Date
Today (50)
Last 7 days (607)
Last 30 days (2047)
Last 365 days (30569)
2026 (2947)
2025 (30985)
2024 (36174)
2023 (41142)
2022 (52395)
2021 (57129)
2020 (55685)
2019 (48421)
2018 (36500)
2017 (33732)
2016 (33293)
2015 (39382)
2014 (32964)
2013 (28116)
2012 (30365)
2011 (30952)
2010 (28779)
Location
Africa (796)
Alabama (84)
Alaska (7)
Arizona (320)
Arkansas (14)
Asia (42408)
Australia (6978)
California (11331)
Canada (3291)
China (1134)
Colorado (480)
Connecticut (482)
Delaware (342)
Europe (92902)
Florida (1671)
Georgia (358)
Hawaii (4)
Idaho (64)
Illinois (897)
India (63)
Indiana (531)
Iowa (23)
Japan (429)
Kansas (130)
Kentucky (40)
Louisiana (27)
Maine (83)
Maryland (1399)
Massachusetts (8147)
Michigan (343)
Minnesota (638)
Mississippi (6)
Missouri (137)
Montana (33)
Nebraska (28)
Nevada (123)
New Hampshire (82)
New Jersey (3031)
New Mexico (30)
New York (2973)
North Carolina (1501)
North Dakota (10)
Northern California (5531)
Ohio (336)
Oklahoma (22)
Oregon (45)
Pennsylvania (2280)
Puerto Rico (22)
Rhode Island (47)
South America (1209)
South Carolina (66)
South Dakota (1)
Southern California (4392)
Tennessee (172)
Texas (1765)
United States (40393)
Utah (341)
Vermont (1)
Virginia (275)
Washington D.C. (82)
Washington State (937)
West Virginia (4)
Wisconsin (113)
Wyoming (2)
752,310 Results for "micron products inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tigermed Completes Acquisition of Japanese CRO Micron
July 29, 2025
·
3 min read
Press Releases
Utah Medical Products, Inc. Announces Quarterly Dividend - February 4, 2026
February 5, 2026
·
1 min read
Genetown
Micron Solutions, Inc. Board Announces Proposal for Stock Splits
Micron Solutions, Inc., through its wholly-owned subsidiary, Micron Products, Inc. announced the Board’s approval of a proposal to effect a 1-for-1,000 reverse stock split of the Company’s Common Stock, followed immediately by a 1,000 to 1 forward stock split for the Company’s Common Stock, which Stock Splits will be enacted through the filing of amendments to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware.
October 2, 2023
·
8 min read
Press Releases
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
February 8, 2026
·
7 min read
Press Releases
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology
June 16, 2025
·
5 min read
Press Releases
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida
New facility increases output, reduces cost of goods sold (COGS) and enhances service for B2B customers to address the forecasted increased demand for products
December 17, 2025
·
5 min read
Press Releases
INCLUSION OF TINENGOTINIB TABLETS IN THE LIST OF PRODUCTS FOR PRIORITY REVIEW BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
December 4, 2025
·
1 min read
Drug Development
Micron Biomedical Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-Free Vaccines in Children
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced the publication of its positive Measles and Rubella (MR) Phase 1/2 trial data in The Lancet Medical Journal.
May 1, 2024
·
5 min read
Business
Micron Biomedical Appoints Global Health Pioneer and Champion of Vaccine Access, Dr. Seth Berkley, as Scientific Advisor to the CEO
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, announced the appointment of global public health pioneer, Dr. Seth Berkley, as scientific advisor to the CEO.
February 27, 2024
·
3 min read
Business
Micron Solutions, Inc. Reports Fourth Quarter and Full Year 2022 Results
Micron Solutions, Inc. (OTCQB: MICR) (the “Company”) announced financial results for its fourth quarter and fiscal year ended December 31, 2022.
March 30, 2023
·
7 min read
1 of 75,231
Next
